HIV, HBsAg & HCV Combo Test

Our Combo Test offers rapid and reliable results, allowing for the detection of HBsAg, HCV antibodies, and HIV 1/2 virus antibodies in a single step. This innovative assay uses specific antigens and monoclonal antibodies, conjugated with colloidal gold and immobilized on the nitrocellulose membrane. When a serum/plasma sample is added, these gold-antigen/antibody conjugates interact with HBsAg, HCV antibodies, and/or HIV1/2 virus antibodies, if present in the sample. The result is the formation of visible pink lines (T1 for HIV, T2 for HBsAg, and T3 for HCV) in the Test Zone (T), indicating positive results for the respective markers. If these markers are absent in the sample, no pink lines will appear in the Test Zone (T), indicating a negative result.

Artron One-Step HIV, HBsAg & HCV Combo Test is a double sandwich immunochromatographic assay, detecting the presence of HBsAg, HCV antibodies and HIV 1/2 virus antibodies, respectively, in human serum/plasma samples. Specific HIV and HCV antigens and monoclonal antibodies specifically against HBsAg are 1) conjugated with colloidal gold and deposited on a conjugate pad, and 2) immobilized on the test line of the Test Zone (Line T1 for HIV, line T2 for HbsAg, line T3 for HCV) on the nitrocellulose membrane. When a serum/plasma sample is added, the gold-antigen / antibody conjugates are rehydrated and the HBsAg, HCV antibodies and/o HIV1/2 virus antibodies, if any in the sample, will interact with the gold conjugates. The antigen-antibody-gold complex will migrate towards the test window until the Test Zone (T) where they will be captured by immobilized specific antigen/antibodies, forming visible pink line(s) (T1, T2 and/or T3); indicating positive result(s). If HBsAg, HCV antibodies, and/or HIV1/2 virus antibodies are absent in the sample, no pink line will appear in the Test Zone (T), indicating a negative result.

Reviews

There are no reviews yet.

Be the first to review “HIV, HBsAg & HCV Combo Test”

Your email address will not be published. Required fields are marked *

Scroll to Top